Clinical Trial

Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome

Name: Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome — clinical trial record (NCT07497776)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 4

View on ClinicalTrials.gov →

Summary

To evaluate the effectiveness and safety of Atorvastatin therapy in children with dyslipidemia in steroid sensitive nephrotic syndrome.

Trial Details

NCT Number	NCT07497776
Lead Sponsor	National Institute of Kidney Disease and Urology (NIKDU)
Conditions	Dyslipidaemia
Enrollment	100 participants
Start Date	2024-01-27
Primary Completion	2025-08-30 (estimated)
Study Completion	2025-10-31 (estimated)
Updated on ClinicalTrials.gov	2026-03-27